mRNA cancer therapeutics specialist CureVac AG has baged US$50m upfront and is eglible to receive up to US$1.7bn in...
From preclinical development to market approval, biopharma companies increasingly rely on outsourcing to biomanufacturing experts and contract...
Berlin Conference on Life Sciences
02.03.2018 in Berlin, Germany
The 11th conference will explore the exciting market for the development of novel antimicrobials and AMR diagnostics.
06.11.2017 in Berlin, Germany
Europe’s largest life science partnering conference, brings together the worldʼs most innovative leaders across biotech, finance and pharma for high-level networking.